A

Acella Pharmaceuticals

Acella agreed to a $41.4 million settlement over false advertising claims related to NP Thyroid medication.

ClosedUnited States-wideClaim status: Closed on November 30, 2024Payout: $50No longer claimable

About this settlement

Settlement for false advertising claims regarding the active ingredient content in NP Thyroid medication.

This settlement resolves claims that Acella Pharmaceuticals falsely advertised the NP Thyroid medication as containing a specified amount of the active ingredient. Eligible individuals who received NP Thyroid prescriptions during the specified period may claim $50 each.

Who qualifies

  • Individuals who received a dispensed prescription for NP Thyroid between May 12, 2018 and April 30, 2021.
  • Eligibility applies regardless of whether the NP Thyroid lots were recalled.

$50

Claim status: Closed on November 30, 2024

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon